Cleared Traditional

K160401 - Tyto Stethoscope

K160401 is an FDA 510(k) clearance for Tyto Stethoscope, manufactured by Tyto Care , Ltd.. The device is a Class 2 Cardiovascular device with product code DQD cleared through the Traditional 510(k) pathway after a 250-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2016
Decision
250d
Days
Class 2
Risk

K160401 is an FDA 510(k) clearance for the Tyto Stethoscope. Classified as Stethoscope, Electronic (product code DQD), Class II - Special Controls.

Submitted by Tyto Care , Ltd. (Netanya, IL). The FDA issued a Cleared decision on October 19, 2016 after a review of 250 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1875 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Tyto Care , Ltd. devices

FDA 510(k) Submission Details - K160401

510(k) Number K160401 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 12, 2016
Decision Date October 19, 2016
Days to Decision 250 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
125d slower than avg
Panel avg: 125d · This submission: 250d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQD Device Classification - Class 2, Special Controls

Product Code DQD Stethoscope, Electronic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1875
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Biomedical Strategy
Orna Oz

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DQD Stethoscope, Electronic

All 106
Devices cleared under the same product code (DQD) and FDA review panel - the closest regulatory comparables to K160401.
CADence System
K170928 · Aum Cardiovascular, Inc. · Aug 2017
Eko Model E5 System (EME5), Eko DUO
K170874 · Eko Devices, Inc. · May 2017
Adscope 658 Electronic Stethoscope
K162589 · American Diagnostic Corp. · Mar 2017
Electronic Stethoscope DS301
K160023 · Imediplus, Inc. · Sep 2016
Steth IO
K160016 · Stratoscientific, Inc. · Jul 2016
AbStats Gateway
K150782 · Gi Logic, Inc. · Dec 2015